Shi Tingting, Wu Li, Ma Wenjun, Ju Liping, Bai Minghui, Chen Xiaowei, Liu Shourong, Yang Xingxin, Shi Junping
The Hangzhou Xixi Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou 310023, Zhejiang, China.
Center of Clinical Evaluation, The First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Youdian Road, Hangzhou 310006, Zhejiang, China.
Evid Based Complement Alternat Med. 2020 Jan 4;2020:8749564. doi: 10.1155/2020/8749564. eCollection 2020.
Nonalcoholic Fatty Liver Disease NAFLD) is one of the most important causes of liver disease worldwide and probably destined to become the leading cause of end-stage liver disease in the coming decades, affecting both adults and children. Faced with the severe challenges for the prevention and control of NAFLD, this article discusses the understanding and mechanism of NAFLD from Chinese and Western medicine. Moreover, the progress regarding its treatment in both Chinese and Western medicine is also summarized. Both Chinese medicine and Western medicine have their own characteristics and clinical efficacy advantages in treating diseases. The purpose of this article is to hope that Chinese and Western medicine have complementary advantages, complementing each other to improve clinical NAFLD therapy prevention and treatment methods to receive more and more attention throughout the global medical community.
非酒精性脂肪性肝病（NAFLD）是全球肝病的最重要病因之一，并且在未来几十年可能注定会成为终末期肝病的主要病因，影响成人和儿童。面对非酒精性脂肪性肝病防控的严峻挑战，本文从中西医角度探讨了对非酒精性脂肪性肝病的认识及发病机制。此外，还总结了中西医在其治疗方面的进展。中西医在疾病治疗方面都有各自的特点和临床疗效优势。本文旨在希望中西医优势互补，相互补充以改进临床非酒精性脂肪性肝病的防治方法，从而在全球医学界受到越来越多的关注。
